Covid: MHRA approve new Covid vaccine Valneva – ‘adverse reactions’

Valneva ships first doses of COVID-19 vaccine on April 6th

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

The sixth Covid vaccine is also the first whole-virus inactive Covid vaccine to gain regulatory approval in the UK. This is where the virus is grown in a laboratory and then made completely inactive. Doctor June Raine, MHRA Chief Executive, said: “Our approval of the COVID-19 vaccine made by Valneva today follows a rigorous review of the safety, quality and effectiveness of this vaccine.” Co-signed by the Commission on Human Medicines, the chair of the body, Professor Sir Munir Pirmohamed said: “We have advised that the benefit risk balance is positive.”

As with any medicines available to the public, there are reactions that could happen.

The MHRA reported on the “undesirable effects” Valneva could lead to (based on current research).

This is a breaking news story with more information to shortly follow…  

Source: Read Full Article